Evidence map›Paper›PMID 21749935›Full record

ArticleBiochimica et biophysica acta2011

Transient model of thermal deactivation of enzymes.

Nelson G Chen, Kalvin Gregory, Ye Sun, Val Golovlev

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nelson G ChenSci-Tec, Knoxville, TN, USA. ngchen@aurogene.com
Kalvin Gregory
Ye Sun
Val Golovlev
Sci-Tec (United States) · US

Funding

BIOLUMINESCENT ASSAY FOR GENE EXPRESSION ANALYSISR44GM080037 · NIGMS · SCI-TEC, INC. · PI GOLOVLEV, VAL V. · 2008 to 2009
$729k
NOVEL ASSAY PLATFORM FOR ASESSING PROTEIN KINASE INHIBITORSR43CA141858 · NCI · SCI-TEC, INC. · PI GOLOVLEV, VAL V. · 2009 to 2009
$100k
Bioluminscence Assay for Gene Expression AnalysisR43GM080037 · NIGMS · SCI-TEC, INC. · PI GOLOVLEV, VAL V. · 2006 to 2006
$100k
NCI NIH HHS R43 CA141858NCI NIH HHS R43CA141858NIGMS NIH HHS R43 GM080037NIGMS NIH HHS R44 GM080037PHS HHS RGM080037
6 · The paper itself

Abstract

The kinetics of enzyme deactivation provide useful insights on processes that determine the level of biological function of any enzyme. Photinus pyralis (firefly) luciferase is a convenient enzyme system for studying mechanisms and kinetics of enzyme deactivation, refolding, and denaturation caused by various external factors, physical or chemical by nature. In this report we present a study of luciferase deactivation caused by increased temperature (i.e., thermal deactivation). We found that deactivation occurs through a reversible intermediate state and can be described by a Transient model that includes active and reversibly inactive states. The model can be used as a general framework for analysis of complex, multiexponential transient kinetics that can be observed for some enzymes by reaction progression assays. In this study the Transient model has been used to develop an analytical model for studying a time course of luciferase deactivation. The model might be applicable toward enzymes in general and can be used to determine if the enzyme exposed to external factors, physical or chemical by nature, undergoes structural transformation consistent with thermal mechanisms of deactivation.

Indexed as

Enzyme ActivationModels, BiologicalProtein DenaturationTemperatureAnimalsEnzyme StabilityFirefliesKineticsLuciferases, FireflyTime FactorsLuciferases, Firefly

Identifiers

PMID21749935
PMCPMC3172083
OpenAlexW2065104522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.